A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of ... as Entresto is its top-selling product, contributing more than ...
Marketing is a top reason name-brand items are more expensive than generics, but there are others. Prestige, supply chain, labor costs, and product development all play a part. Most of the time, ...
Merck's combination of a wide lineup of high-margin drugs and a pipeline of new drugs should ensure strong returns on invested capital over the long term. Further, following the divestment of the ...